Results 151 to 160 of about 42,983 (297)

<Editors' Choice> Myelodysplastic syndrome with trisomy 8 presenting periodic fever and multiple MEFV gene variants outside exon 10: a case report. [PDF]

open access: yesNagoya J Med Sci, 2023
Takahashi N   +10 more
europepmc   +1 more source

Integrated Clinical and Proteomic Profiling of CD19 CAR‐T Cell Therapy in Progressive Systemic Sclerosis

open access: yesArthritis &Rheumatology, Accepted Article.
Objective To characterize the clinical, immunologic, and proteomic changes associated with CD19 chimeric antigen receptor T‐cell therapy in patients with progressive systemic sclerosis. Methods Patients with progressive systemic sclerosis received CD19 CAR‐T cell therapy and were followed longitudinally for safety, clinical efficacy, immune ...
Chenhan Jia   +16 more
wiley   +1 more source

Increased Frequency of Febrile Seizures in Two Periodic Fever Syndromes: Familial Mediterranean Fever and PFAPA Syndrome. [PDF]

open access: yesTurk Arch Pediatr, 2022
Kılıç H   +7 more
europepmc   +1 more source

Periodic Fever, Aphthous Stomatitis, Pharyngitis and Cervical Adenitis (Pfapa) Syndrome

open access: yes, 2015
Ateş, ölçüldüğü yere göre değişmekle birlikte, vücut sıcaklığının ortalama 37ºC'den 1-4ºC daha yüksek olmasıdır. Çocuklarda sık görülen ateş, öncelikle enfeksiyonu akla getiren semptomlardan biridir.
Malbora, Barış, Gökaslan, Filiz
core  

Attempts to identify the molecular cause of autoinflammatory recurrent fever

open access: yes
Systemic autoinflammatory diseases caused by dysregulation of the innate immunity are a known cause of recurrent fevers. We present the molecular diagnosis results of 12 children with recurrent fever, analyzing the correlation between molecular findings ...
Diana Savkiv, Oksana Boyarchuk
core   +1 more source

Switching disease‐modifying therapies in patients with spinal muscular atrophy: A systematic review on effectiveness outcomes

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
With multiple disease‐modifying therapies now available, treatment switching has become an important clinical consideration in the management of spinal muscular atrophy (SMA). While some switches are prompted by suboptimal clinical response, more commonly they are driven by treatment burden, convenience, or adverse events.
Andrej Belančić   +4 more
wiley   +1 more source

Navigating adverse immunostimulation: A practical guide for clinical researchers

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Problem Setting As drug development moves towards more complex products, early clinical development programmes are increasingly hampered by unwanted and/or unexpected activation of the immune system (adverse immune stimulation, AIS). Solution At the Centre for Human Drug Research, we have introduced standardized procedures to make AIS manageable, while
Juliette A. van den Noort   +3 more
wiley   +1 more source

Challenges in the diagnosis of periodic fever, aphthous stomatitis, pharyngitis, and adenitis syndrome in developing countries-A decade of experience from North India. [PDF]

open access: yesFront Immunol, 2022
Banday AZ   +13 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy